IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 96

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Development & Application Of Liposomes In Drug Delivery
Authors Name: Shubham Eknath Urade , Dr. Pankaj N. Sirsat , Ganesh S. Somase , Rajendra D. Mahire
Download E-Certificate: Download
Author Reg. ID:
IJNRD_207912
Published Paper Id: IJNRD2310406
Published In: Volume 8 Issue 10, October-2023
DOI:
Abstract: Liposomes are a group of lipids that have been used for a variety of biological applications, including DNA vaccination and gene therapy. Liposomal drug delivery systems have been utilized in the treatment of various diseases, including cancer, ovarian cancer, and advanced breast cancer. Several drug delivery approaches have been proposed for liposome delivery systems, including small unilamellar vesicles (SUVs), transdermal drug delivery vectors, and DNA vaccines. This review focuses on recent advances in the development and application of liposomal delivery systems. Liposomes have found widespread application in addressing both anterior and posterior segment eye disorders. In addition, they serve as immunoadjuvants in several therapeutic contexts, such as cancer drug therapy and improved gene therapy efficiency.
Keywords: Liposomes, Gene Therapy, Immunoadjuvants, Vaccine, Cancer treatment.
Cite Article: "Development & Application Of Liposomes In Drug Delivery", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 10, page no.e54-e63, October-2023, Available :http://www.ijnrd.org/papers/IJNRD2310406.pdf
Downloads: 000118759
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2310406
Registration ID: 207912
Published In: Volume 8 Issue 10, October-2023
DOI (Digital Object Identifier):
Page No: e54-e63
Country: Nashik District, Maharashtra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2310406
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2310406
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD